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KEY POINTS
 Left atrial appendage occlusion for atrial fibrillation comes with risks of complications such as
improper device sizing with consequent device leak, device embolization, or cardiac injury
 Two-dimensional imaging technologies provide an incomplete understanding of the complexity
of the left atrial appendage anatomy
 Preprocedural planning for left atrial appendage occlusion with cardiac CT is shown to increase
procedural accuracy
 Further benefits can be achieved with 3D printing, computational modeling, artificial
intelligence, as well as intraprocedural 3D angiography and dynamic fusion imaging

INTRODUCTION
Over the course of the last 2 decades, transcatheter structural interventions have experienced
exponential growth and rapid evolution driven
by near-Promethean innovation and multidisciplinary biomedical ingenuity. In the wake
of this development, the need for multimodality imaging for structural heart procedures
has been recognized as an important and arguably essential adjunct used in all phases of the
procedural process. From preprocedural planning and teaching to guidance within the cath
lab, as well as to postprocedural care, structural
imaging is proving to be an indispensable asset
to ensuring procedural success. Given the
inherent complexity of cardiac anatomy, an in-

depth understanding of anatomy and physiology
is vital for the success of structural heart
procedures.
Structural imaging has established its utility in
procedures such as transcatheter aortic valve
replacement (TAVR), mitral valve interventions
such as transcatheter mitral valve replacement
(TMVR) and MitraClip (Abbott, Illinois, USA), as
well as septal defect repairs. For left atrial
appendage occlusion (LAAO), multi-modality
imaging is gaining traction and is, likewise, arguably essential in all phases of procedural planning and execution. In the setting of a global
pandemic with limited access to personal protection equipment for health care providers,
maximizing the efficiency and safety of delivery
of health care using modernized imaging
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technologies has become even more critical.
Our review of the literature seeks to synthesize
the critical thinking methodologies to investing
time in planning for LAAO procedures.

PERCUTANEOUS LEFT ATRIAL
APPENDAGE OCCLUSION
Understanding the Rationale for
Periprocedural Evaluation
Common terminology of the left atrial
appendage anatomy assumes the orifice of the
LAAO landing zone is a circle. With this assumption, 2D transesophageal echocardiogram (TEE)
imaging was instituted as the gold standard of
imaging the LAA for sizing and device selection.
Optimal viewing angles were depicted as 0, 45,
90, and 135 . However, the arrival of multidetector CT has demonstrated the LAA’s landing zone to be elliptical and at times amorphous
in shape with multiple angulations that are
unique to each patient’s anatomy. Traditional
2D TEE and the narrow imaging field of 2D intracardiac echo (ICE) are unable to visualize the full
dimensions of the LAA due to the inability of operators to obtain coaxiality to the true maximal
dimensions of the LAA. Hence, modern day
LAAO implantation outcomes in the published
literature have not achieved 100% procedural
success rates. Increasing procedural success
and safety outcomes of LAAO technologies requires an in-depth preoperative understanding
of each patient’s unique LAA anatomy.

Procedure details
In the United States, the WATCHMAN (Boston
Scientific,
Marlborough,
Massachusetts),
WATCHMAN FLX (Boston Scientific, Marlborough, Massachusetts) and Amulet (Abbott,
Abbott Park, Illinois) have received approval by
the Food and Drug Administration for the prevention of stroke in patients with atrial fibrillation
(AF).1 The FLX and the Amulet LAAO devices are
seated in the LAA, the most common site of
intracardiac thrombus formation in AF, to prevent thrombi from forming within it thereby
preventing cardio-embolic phenomenon.2–4
Due to timing of FDA regulatory approval,
currently, the most widely studied LAAO devices
in the United States are the WATCHMAN and
WATCHMAN FLX LAAO systems. Hence, subsequent procedural details will focus on
WATCHMAN FLX delivery systems.
The WATCHMAN FLX LAAO procedure itself
begins with obtaining femoral venous access.
Transseptal puncture is performed, usually under TEE guidance, to enter into the left atrium
(Fig. 1). The optimal transseptal puncture site

assessed by TEE is often limited by the fact
that we are obtaining 2D images of a 3D structure. Assessing whether one is puncturing too
anterior or posterior in the septal plane is difficult. Furthermore, the generation of 3D images,
although possible, is limited by the quality of the
initial 2D images obtained, which may not
render a very precise assessment and execution
of this maneuver.
Once transseptal puncture is performed, a
guidewire is sent to the left atrium and into the
left superior pulmonary vein. The WATCHMAN
or WATCHMAN FLX access sheath and dilator
are advanced over the guidewire into the left
atrium. Dilator and guidewire are removed followed by the advancement of the angled pigtail
catheter through the WATCHMAN access sheath
into the distal portion of the main lobe of the LAA
for the contrast visualization of the LAA.5 Next,
the access sheath is advanced into the LAA over
the pigtail catheter until the access sheath radiopaque marker band meets the corresponding
device size marker band or is just distal to the
LAA ostium. Once identified, the pigtail catheter
is removed, and the LAA occluder delivery system is advanced through the access sheath. Under fluoroscopic guidance, the delivery system’s
distal marker band is aligned to the distal marker
of the access sheath.5 Traditionally, confirmation
of delivery sheath positioning and coaxiality is
verified by TEE. Both fluoroscopic and TEE verification of coaxiality are primarily by 2D images
that, by nature, confer an incomplete overall visualization of the LAA ostium and optimal coaxial
positioning, which may lead to incomplete
seating of the LAA occlude, device leaks, among
other complications.
The WATCHMAN FLX device is then
deployed into the LAA via a combination of passive exposure and advancement of the FLX ball,
consisting of retracting the access sheath and
delivery system while stabilizing the deployment
knob. After the deployment of the device, positioning is evaluated under TEE guidance and
contrast fluoroscopy. Specific criteria of appropriate positioning must be met, which includes
position, anchor, size, and seal (PASS). Ideally,
the LAA occluder would be placed at the level
of the circumflex artery with minimal protrusion
into the left atrium. A “tug test” is then performed, for which the deployment knob is pulled
and the LAAO device is visualized under fluoroscopy, confirming adequate anchoring of the device. Device compression should be at a
minimum of 8%, and peridevice flow should be
no more than 5 mm at vena contracta on 2D
TEE color flow.
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Fig. 1. The WATCHMAN
(A) and WATCHMAN FLX
(B) devices. The original
WATCHMAN is a selfexpanding nitinol structure
with a porous polyethylene
terephthalate (PET) membrane
on the proximal face. The
WATCHMAN FLX is a modified
version with the rearrangement
of the nitinol structure at the
distal end into a rounded
configuration and extension of
the PET membrane distally.

Pre-cath Laboratory Planning in Left Atrial
Appendage Occlusion
Traditionally, two-dimensional TEE had been the
sole imaging modality to guide LAAO procedures until 2011, when computed tomography
(CT) began being integrated into cath laboratory
planning and postprocedure monitoring.6 While
CT had become standard of care for transcatheter device planning, such as for TAVR and
transcatheter mitral replacement therapies, it
had not been in use for LAAO until recently.7,8
Stand-alone fluoroscopic sizing for LAA in the
cardiac catheterization or electrophysiology laboratory without preprocedural imaging has
several limitations. Contrast injection with fluoroscopic evaluation in multiple c-arm angle projections provides an overview of the shape of the
LAA but is unable to verify maximal coaxial alignment to the true orifice of the LAA landing zone.
Off-axis fluoroscopic projections of the LAA may
lead to under or oversizing of the LAA landing
zone, and the inability to appreciate challenging
anatomy. Hence, in patients without access to
intraprocedural TEE or preprocedural CT imaging planning, pure fluoroscopic guidance has a
lower device implantation success rate than
with standard of care TEE imaging guidance.
This may result in aborted LAAO procedures
due to inappropriate anatomy for the devices
available, or LAA anatomy that may not have
been compatible with any commercially available device.
However, TEE for LAA closure, although an
additive value to fluoroscopic imaging alone, itself also has inherent limitations. Patients undergoing outpatient TEE are usually volume
depleted due to necessary fasting nothing by
mouth requirements before the procedure. As
the LAA volume depends on loading conditions,
TEE can certainly underestimate the LAA dimensions.9 Also, the spatial resolution of TEE is
limited and somewhat operator- and image

quality dependent, which may lead to the underappreciation of LAA contractility and dimensions
changes during the cardiac cycle.10
Furthermore, in the setting of the 2019 global
SARS-CoV-2 pandemic, access to outpatient
preprocedural TEE became a barrier to scheduling patients for LAAO procedures. Given the
inherent risks of aerosolization procedures and
spread of SARS-CoV-2 coupled with a limited
global supply of personal protection equipment,
echocardiography laboratories across the world
decreased their elective TEE procedural volume
to ration the supply of personal protection
equipment.11,12 In some countries, once the supply of personal protection equipment for health
care providers became more readily available,
mandatory nasopharyngeal swab testing for
COVID-19 before any preprocedural TEE
became a secondary deterrent for patient’s
seeking access to LAAO procedures. Hence, a
migration away from preprocedural TEE has
been accelerated by the global pandemic into
alternative additive technologies to support
intraprocedural case guidance.

Planning Modalities
Left atrial appendage occlusion is a procedure
that has the potential to attain immense gains
from not only the integration of CT but also of
other imaging modalities as well such as 3D
printing, computational modeling (CM), and artificial intelligence (AI).
Computed Tomography
Preprocedural planning for LAAO now consists
not only of TEE imaging but also multidetector ECG-gated, contrast-enhanced cardiac
CT. Modern advanced dual-source cardiac CT
scanners allow for adequate image acquisition
and evaluation of patients with irregular heart
rates due to post-scan additive features such
as EKG editing.13 The benefits of CT imaging
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before LAAO are manifold, ranging from the
assessment of patient appropriateness (eg,
congenitally-absent LAA, prior surgical or transcatheter device, or the presence of LAA
thrombus), to the structural characterization of
the LAA itself, as well as accurate sizing of the
device and localization of the appropriate landing zones of the LAA occluder with precision
(Fig. 2). Furthermore, CT images can be further
processed to form 3D print models, which can
offer substantial preprocedural planning.

3D printing
Three-dimensional printing is a method of
manufacturing three-dimensional physical objects from information derived from digital
media (Fig. 3).14 The process of forming threedimensional physical objects starts with obtaining high-quality imaging data and its conversion
to a Digital Imaging and Communication in Medicine (DICOM) format for further image processing. Processing is done through special software
to define and build the anatomic body parts of
interest in a process called segmentation. Subsequently, 3D volume rendering and digital
modeling of patient-specific anatomy are constructed. Patient-specific 3D digital anatomic
models are then saved in a stereolithography
(STL) file format, which contains the surface
mesh information of the specific geometries to
be used in the 3D printing process, which can
be further refined by computer-aided design
modeling and computational analysis. Finally, a
3D print model is made by processing and using
this digital information to create physical objects
by depositing multiple layers of material over
digitally defined geometries.
Three-dimensional print models have demonstrated that patient anatomy is much more complex than what is understood by traditional two
dimensional TEE imaging alone (Fig. 4).14,15
The clinical implications of this is that our knowledge of LAAO device sizing as well as identifying
appropriate
landing
zone
and
deployment, is far more primitive than what

was previously understood, as may have been
our clinical decisions using traditional imaging
methods. Three-dimensional printing has great
implications for improving procedural accuracy,
device sizing, and time to reaching the early
operator learning curve, among many other
benefits.7,14,15

Intraprocedural 3D angiography
Rotational angiography or 3D angiography is an
imaging modality that allows intraprocedural
reconstruction of a 3D model of a chamber of interest such as the LA (including the LAA),
yielding datasets much like those derived from
cardiac CT. Images can be overlaid on 2D fluoroscopy for anatomic guidance and can be
used for LAA sizing and device selection as an
alternative to TEE. As the images are acquired
on the same table using the same equipment
as the 2D fluoroscopy, they can be used to visualize the ideal angulation of the fluoroscopy tube
for a particular LAA, eliminating issues of foreshortening.16 As these images are obtained by
contrast injection during apnea and rapid ventricular pacing, a workflow using general anesthesia is typically required for obtaining good
image quality.
Dynamic fusion imaging
In day-to-day practice, physicians performing
LAA closure have to be able to synthesize and
recreate the images obtained by different imaging modalities and techniques into one 3D understanding of the LAA in their mind. However,
when initial image acquisition is only performed
with 2D TEE or fluoroscopic datasets, a full understanding of the LAA may not be possible.
Currently, pre-procedural CT generated LAA
caseplans are not able to be fused onto fluoroscopic displays. Hence, the role of dynamic
fusion imaging in LAAO is gaining greater interest in the transcatheter arena.
The dynamic fusion imaging technique has the
ability to merge the information obtained from
different methods onto one fluoroscopic display.
Fig. 2. (A) The WATCHMAN
device is produced in various
sizes, as shown above. (B)
The WATCHMAN FLX comes
in the following sizes from left
to right: 20 mm, 24 mm,
27 mm, 31 mm, and 35 mm.
(C) CT-guided LAA sizing to
aid in choosing the appropriate device size. (Images
from Boston Scientific. ª

2021 Boston Scientific Corporation or its affiliates. All rights reserved.)
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Fig. 3. The process of LAA
image acquisition and processing is displayed in this
figure. (A) A series of frames
was taken during CT imaging
for visualizing the appendage
and its landing zone with accurate measuring of the
maximum
and
minimum
diameter, LAA orifice area,
and length of LAA from the
landing zone. The CT images
are
processed
via
3D
volume-rendering into a digital format and structure (B),
which in turn can be used to
create 3D print models (C)
for a more in-depth understanding of LAA anatomy
and for the use of preprocedural simulation. The 3D
model demonstrates the fossa ovalis (bottom left & bottom right, labeled as FO) between the SVC and IVC,
demonstrating optimal transseptal puncture site. The WATCHMAN device is seen well-seated in the LAA orifice.
FO: fossa ovalis, IVC: inferior vena cava, LA: left atrium, LAA: left atrial appendage, SVC: superior vena cava.

Specifically, for LAA closure, anatomic landmarks
identified by TEE or CT are directly overlaid on
the real-time fluoroscopy, the latter typically
being superior for identifying the closure device itself. Thus, these systems aim to generate a single

final real-time hybrid visualization of the aforementioned techniques, improving safety and reducing
procedural times. Several vendors offer integrated
TEE/fluoroscopy or 3DRA/fluoroscopy modalities
(Fig. 5).17–20

Fig. 4. Images of left atrial appendage taken by TEE in various standard views to take measurements of the
appendage (A). As seen from left to right, these views are taken approximately at 0, 45, 90, and 135 . Transesophageal echocardiography gives us an incomplete understanding of the true complex nature of LAA anatomy (B).
These are 3D images of the left atrium and LAA taken from the same patient’s CT scan images. One can see the
complex entry point and curved direction the appendage takes, which would have significant implications on device sizing and deployment. LA: left atrium, LAA: left atrial appendage, LLPV: left lower pulmonary vein, LUPV: left
upper pulmonary vein.
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Fig. 5. This figure shows a 3D model of the LA,
partially cut-away. A Watchman delivery sheath with
a loaded Watchman device is positioned in the LAA
and is ready for deployment. LA: left atrium, LAA:
left atrial appendage.

Computational modeling
CM is a method in which digital 3D reconstructions of any object can be illustrated in a 4D
manner over time.21 Used in biomedical engineering and sciences, CM fills the void that static
models have in exemplifying the complex
anatomic and physiologic interplay that occurs
in real time. About 15 years ago, while in its infancy, computational models were created by
simple manual drawings of geometric shapes.
Today, the use of multi-modality imaging, such
as CT and MRI in the case of cardiac models, is
used for more refined and patient-specific
modeling.21 Through finite element analysis
(FEA) and computational fluid dynamics (CFD),
computational models can recreate stress and
deformation of cardiac tissue, as well as to characterize the blood flow pattern in a patient’s
heart.14,22
The benefits of CM would be manifold, as it
would allow for a way to take static cardiac images and bring them to life. This would give operators a greater understanding and sense of the
physiologic environment in which they must
operate. As such, CM may offer unique insights
and even greater improvement in operator skill
as well as procedural success.
Artificial intelligence
AI is defined as the study of algorithms that give
machines the ability to reason and perform functions such as problem-solving, object and word
recognition, inference of world states, and

decision-making.23 AI has various applications
across multiple disciplines, and it has recently
found its way into improving precisionmedicine and health care. Several procedural
specialties have demonstrated the utility and accuracy offered by AI in training and procedure
simulation, from general surgery, to anesthesiology, and even to neurosurgery, amongst
many more.23–25 Bissonnette and colleagues
demonstrated the successful use of AI via machine learning algorithms in a surgical laminectomy simulation.25 They showed that use of AI
in their simulation achieved 97.6% accuracy in
various metrics including the safety of the procedure, efficiency, motion of the tools, and coordination. Moreover, Engelhardt and colleagues
used a deep neural network and recreation of
the surgical scene to train operators for minimally invasive mitral valve repair, demonstrating
its success in significantly improving their skills,
understanding of complex mitral valve anatomy
and surgical technique, and therefore,
decreasing the time to crossing the learning
curve.26 As such, AI may have great potential
in similarly improving accuracy, efficiency, and
success in training for structural heart
procedures.

Benefits of Pre-Cath Laboratory Planning
Patient selection
Many patients are not appropriate anatomical
candidates for LAAO. Some individuals have a
congenital absence of the LAA, others may
have prior surgical and catheter interventions
that preclude entry into the LAA, and lastly
some patients may have an LAA thrombus present. Computed tomography is useful in pre-procedural planning to accurately characterize the
above possible limitations or patient-specific contraindications to the procedure. Moreover, some
patients may not be deemed a candidate for current generation LAAO devices due to LAA size
and anatomy that is considered incompatible
with their patient specific anatomy. However, in
the setting of inadequate pre-procedural imaging, some patients may be deemed not a candidate
for
LAAO
due
to
incomplete
understanding of their patient specific anatomy,
when in actuality they may have been anatomically suitable for LAAO by in-depth CT analysis.27
Alternatively, some patients by pre-procedural
2D TEE or angiography may be deemed a candidate for LAAO, only to find intraprocedurally that
the patient anatomy may not truly be amenable
to any LAA occluder, rendering the patient with
an aborted attempt at LAAO with failed attempt
at stroke prevention.
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Thrombus visualization
Cardiac CT is a noninvasive modality that offers
important information not only of one’s LAA
anatomy but also of the presence or absence
of LAA thrombus. Cardiac CT for LAAO is
contrast-enhanced; therefore, a LAA thrombus
is immediately visualized as a filling defect that
should otherwise not be present. This mitigates
the need for invasive tests such as TEE before
LAAO for thrombus visualization and therefore
mitigates health care spending and multiple
medical encounters for the patient.
Device sizing and procedure simulation
It is clear that there exists an early-operator
learning curve in LAAO device sizing and implantation.14
Multi-modality
imaging
is
extremely helpful in the appropriate sizing of
the LAA, and accurate selection of the size of
the LAAO device to be deployed. In fact, there
is a significant difference in device size selection
and less change in device size intraprocedurally
with a greater success rate of device implantation in those with both CT and TEE guidance
compared with TEE alone.27 As shown in
Fig. 2, there are various sizes offered for the
WATCHMAN and WATCHMAN FLX devices. In
cardiac CT, the LAA landing zone is appropriately sized at maximal LAA diastole or mid-late
left ventricular systole (see Fig. 2). This is the
moment in the cardiac cycle for which the LAA
is at its largest, and therefore, an ideal phase
for device sizing to mitigate risks of undersizing, and therefore, the risk of peridevice leaks
and device embolization.28
Furthermore, CT images can be processed
into 3D print models, which can offer finer detail
and understanding of a patient’s LAA anatomy.
This can provide further granularity in sizing and
successful mitigation of the above-mentioned
risks. There is immense variability in LAA anatomy
and structure from patient-to-patient, which is
not readily seen in traditional echocardiographic
techniques (see Fig. 4). This adds to further
complexity in achieving success in LAAO,
including device sizing, appropriate transseptal
puncture, as well as device deployment.
CT imaging and 3D print models are
extremely useful, particularly in LAAO procedure
simulation. Printed models render a better understanding not only of complex LAA anatomy
but also exhibit the visualization of left atrial
size and dimensions for improved procedural
planning. Accurate identification of the landing
zone, simulation of transseptal puncture, appropriate catheter sizing for better deployment,
and optimal C-arm angulations can all be

determined with 3D print model-based simulation. In fact, one randomized study comparing
LAAO guided by 3D-CT and 3D printing versus
2D TEE demonstrated significantly improved accuracy in device sizing (92% vs 27%, P 5 .01),
improved procedural efficiency (55  17 min vs
73  24 min, P < .05), and fewer C-arm viewing
projections (1.3  1.2 vs 3.25  2.52, P 5 .05).15
Moreover, fewer devices and guide catheters
were used in the former group compared with
the 2D TEE cohort, namely due to preprocedural
planning and simulation.15
As a result, early operator learning curves
may significantly decrease with preprocedural
3D-CT and printed models.7 Simulation offers
the opportunity to teach trainees and early operators in a more effective way, further
decreasing the time to crossing the learning
curve. One study demonstrated a 100% success
rate of LAAO with 1.245 devices per implantation attempt, compared with the average 1.8
devices per LAAO attempt (82% success rate)
in the PROTECT-AF study.7,29 Moreover, only
4 out of the 53 patients had peridevice leaks
and no device embolization noted in the
cohort.7
Although CT and 3D printing offer a more accurate understanding of the complexities of LAA
anatomy, these offer static views without the live
mechanics and physiology of a beating heart.
Computational modeling opens a window into
a more complete understanding of dynamic
anatomy. Through computational simulation via
methods such as FEA and CFD, these methods
would provide further advantages in preprocedural planning. In addition to understanding
static anatomy, computational modeling mimics
reality with dynamic anatomy, offering a better
understanding of real-time tissue deformation
blood flow dynamics. Limitations to current
widespread medical adaptation of computational modeling, such as FEA and CFD-based
tools, include a paucity of easy-to-use medical
grade softwares for medical teams in clinical
practice, lack of clinical reimbursement, and
absence of engineering expertise in integration
of these tools to clinical practice.
Likewise, AI may even further individualize
patient care when used in structural heart procedure planning. When used combination with
3D printing, AI may assist in the manufacturing
of patient-specific anatomic replica, as well as
real-time procedure simulation tailored to the
patient’s anatomy and physiology.14 Through
AI, patient-specific anatomy and physiology
may be reconstructed to provide a framework
for preprocedural planning and practice with
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instantaneous feedback in a much more realistic
setting.

Patient education
The use of 3D print models is effective not only
in periprocedural planning but also may be
considerably advantageous in patient education.
Integration of 3D prints into clinical practice facilitates the shared decision-making between
the patient and the physician. 3D print models
can be used in the clinic setting to discuss therapeutic options in a much more visual, and
therefore, effective way, rendering a much
greater level of comprehension by the patient.
This has led to further patient engagement in
discussion with their physician, and therefore,
better-informed decisions, and improved patient satisfaction. Application of 3D prints in
clinical visits empowers patients with greater
comprehension and knowledge of their disease,
personal anatomy, and procedural recommendations for their care.30–32
Limitations of Preprocedural Planning
Preprocedural planning is not critical to the successful development of an LAAO program in all
hospitals. Operators and Interventional Imaging
physician teams with significant preexisting
expertise in LAAO procedures may not experience a significant additive value of periprocedural planning to their case outcomes.
Additionally, depending on the size of the population served by the local health system, not all
hospitals will have the same anticipated annual
volume of LAAO procedures. Smaller sized
LAAO programs may not have the financial
reservoir necessary for the purchase of dedicated cardiac computed tomographic scanners
for structural procedures. Additionally, in an
era whereby reimbursement for cardiac coronary
CT scanning is already challenging, reimbursement for the professional time necessary for performing intra or periprocedural structural heart
CT planning is lacking. Modern intraprocedural
techniques such as 3D angiography require
training and experience, and both 3D angiography, as well as TEE fusion imaging, require
capital equipment investments. Lastly, disparities in access to health care and reimbursement
to new technologies vary by county and country
delivering patient care and hence may limit
Implanting Team’s access to change their delivery of care.

SUMMARY
Preprocedure planning for LAAO is critical to
ensuring patient safety, procedural success,

and optimal device outcomes for patient care.
Pre-cath laboratory planning for LAAO can
significantly improve procedural efficiency, accuracy, success, and therefore cost-effectiveness.
In addition to multi-modality imaging, various
modes of recreating cardiac anatomy and physiology, namely via 3D printing, computational
modeling, and AI, can aid in significant improvements in achieving greater understanding of
unique patient-specific anatomic and physiologic considerations in the procedural setting.
The scalability of periprocedural planning in
transcatheter interventions remains a discussion
limited by regional practice patterns and solvent
reimbursement strategies. As the LAAO procedure becomes more available globally, education
on the importance of preprocedural LAAO planning is lagging. To ensure optimal safety and
procedural success between the hands of experienced operators and new operators with new
devices, preprocedural LAAO planning is
invaluable.

CLINICS CARE POINTS

 Current data support the use of preprocedural CT as additive value for
improving accuracy of LAA device sizing and
procedural success.
 For any new LAAO implanter, incorporation
of pre-procedural CT derived 3D printing
and computational modeling decreases early
operator learning curves associated with
learning new devices and cardiac anatomies.
 Establishment of preprocedural imaging
support protocols and pathways require
institutional and societal investment in
educational and reimbursment pathways for
interventional imaging physicians to assist the
Heart Team approach to LAAO procedures.
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